China Tobacco International (HK) Company Limited – Annual Report 2025: Key Highlights and Investor Insights

Strong Financial Performance and Dividend Growth

China Tobacco International (HK) Company Limited (“CTIHK” or “the Company”) has delivered robust financial results for the year ended 31 December 2025. The Group reported a revenue of HK\$14.58 billion, an 11.5% increase year-on-year, and a gross profit of HK\$1.47 billion, up 6.9%. Profit attributable to equity shareholders surged by 14.8% to HK\$980.3 million. Earnings per share (basic and diluted) also rose by 15.4% to HK\$1.42.

Notably, the Board recommended a final dividend of HK\$0.33 per share, bringing the total dividend for the year to HK\$0.52 per share, reflecting a 13% increase. The Company’s dividend growth signals strong profitability and commitment to shareholder returns.

Shareholder Return Index Outperformance

CTIHK’s Shareholder Return Index has significantly outperformed the Tracker Fund of Hong Kong (Hang Seng Index) since its listing in June 2019. As of December 2025, CTIHK’s index reached 759, compared to 110 for the Tracker Fund, demonstrating substantial share price appreciation and dividend income. This historic outperformance may be price sensitive and positively influence investor sentiment.

Business Segment Achievements and Expansion

• Tobacco Leaf Import Business: The Group proactively managed trade risks, secured timely arrivals of imported tobacco leaves, and expanded sourcing channels for cigar tobacco leaf raw materials, especially in Central and South America. This diversification is expected to bolster supply chain resilience and margins.
• Cigarettes Export Business: This segment was a major profit driver, benefiting from international market expansion and reduced finance costs, supporting overall growth.
• Brazil Operation Business: The Group continues to invest in procurement, processing, and sale of tobacco leaves and agricultural materials, targeting global markets.
• New Tobacco Products Export Business: Export of new tobacco products (excluding Chinese Mainland) remains a strategic focus, aligning with global tobacco industry trends and regulatory shifts.

Operational Efficiencies and Cost Management

The Group’s finance costs decreased by 21.3% to HK\$176.3 million, primarily due to lower bank borrowings and interest rates. Improved capital operation efficiency, risk management, and internal controls contributed to profitability and cash flow stability. Net assets increased by 20.7%, and cash and cash equivalents reached HK\$3.31 billion, a 15.9% rise.

CTIHK’s current ratio improved to 1.68, indicating enhanced liquidity. Conservative treasury policies and tight risk controls ensure surplus cash is placed in short-term deposits, mainly in HKD and USD.

Corporate Governance, Compliance, and ESG Initiatives

The Company maintained high corporate governance standards, fully complying with the Corporate Governance Code and Model Code. There were no material non-compliance incidents in Hong Kong or Brazil. The Group established the “GROW” sustainability strategy, launched “Green Pulsation” and “Together Moving Forward” programs, and expanded ESG data collection (including Scope 3 GHG emissions). These initiatives enhance transparency, risk mitigation, and market trust.

Connected Transactions and Regulatory Compliance

CTIHK has robust controls over connected transactions, with comprehensive reviews by independent non-executive directors, auditors, and financial advisers. All transactions were conducted in the ordinary course of business, on normal commercial terms, and in the interests of shareholders. The Company complied with all reporting, announcement, and cap requirements under HKEX Listing Rules.

Shareholder Structure and Public Float

As of 31 December 2025, CTIG held 72.29% of the Company’s shares, with CNTC deemed to have the same interest. The Company maintained a public float of at least 25%, meeting HKEX requirements.

Use of IPO Proceeds and Capital Management

Of the HK\$904 million raised from the IPO and over-allotment, HK\$416.1 million remains unutilised as at 31 December 2025, earmarked for investments, business growth, and strategic cooperation, expected to be used by 30 June 2027. No equity-linked agreements or major capital asset plans were entered during the year.

Risks and Uncertainties

• Global Tobacco-Control Campaigns: Increasing regulatory and health concerns may affect demand for tobacco products and pose downside risks to revenues.
• Seasonality: Results may fluctuate due to the seasonal nature of tobacco leaf import/export.
• Regulatory Approvals: Some business segments depend on periodic plans approved by relevant authorities.

Corporate Events and Investor Relations

• Annual General Meeting scheduled for 29 May 2026.
• Final dividend payment expected on 26 June 2026.
• Management actively engaged with investors, attending 231 conferences and meeting 348 investors and analysts in 2025.
• Comprehensive shareholder communication policy and dedicated securities affairs department ensure transparency and active dialogue with investors.

Key Takeaways for Investors

• CTIHK’s strong financial results, dividend growth, and historic share price outperformance are likely to positively impact the share value.
• Business expansion, operational efficiency, and ESG leadership position the Company for sustainable growth.
• Risks from global tobacco-control campaigns and regulatory shifts remain, but the Company’s diversified sourcing and international focus may mitigate these.
• Significant cash reserves, prudent capital management, and ongoing investment plans support future development.

Disclaimer:

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should carefully review the full annual report and consult professional advisers before making investment decisions. Past performance is not indicative of future results.

View CTIHK Historical chart here